292 related articles for article (PubMed ID: 25165123)
1. Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from Western Canada, 2009 to 2013.
Law DKS; Zhou J; Deng S; Hoang L; Tyrrell G; Horsman G; Wylie J; Tsang RSW
J Med Microbiol; 2014 Nov; 63(Pt 11):1490-1499. PubMed ID: 25165123
[TBL] [Abstract][Full Text] [Related]
2. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
[TBL] [Abstract][Full Text] [Related]
4. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
[TBL] [Abstract][Full Text] [Related]
5. Characterization of invasive meningococcal disease case isolates in Atlantic Canada, 2014 to 2020: spatial-temporal variations of clones and predicted meningococcal B vaccine coverage.
Tsang RSW; Law DKS; Zhou J; Haldane D; Garceau R; Zahariadis G; Mead K; Alexander D
J Med Microbiol; 2022 Dec; 71(12):. PubMed ID: 36748536
[No Abstract] [Full Text] [Related]
6. Characterization of invasive Neisseria meningitidis isolates recovered from children in Turkey during a period of increased serogroup B disease, 2013-2017.
Ceyhan M; Ozsurekci Y; Lucidarme J; Borrow R;
Vaccine; 2020 Apr; 38(19):3545-3552. PubMed ID: 32199701
[TBL] [Abstract][Full Text] [Related]
7. Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
Biolchi A; De Angelis G; Moschioni M; Tomei S; Brunelli B; Giuliani M; Bambini S; Borrow R; Claus H; Gorla MCO; Hong E; Lemos APS; Lucidarme J; Taha MK; Vogel U; Comanducci M; Budroni S; Giuliani MM; Rappuoli R; Pizza M; Boucher P
Vaccine; 2020 Nov; 38(47):7542-7550. PubMed ID: 33036804
[TBL] [Abstract][Full Text] [Related]
8. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
[No Abstract] [Full Text] [Related]
9. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
Waśko I; Gołębiewska A; Kiedrowska M; Ronkiewicz P; Wróbel-Pawelczyk I; Kuch A; Hong E; Skoczyńska A
Vaccine; 2020 Feb; 38(8):1943-1952. PubMed ID: 31980191
[TBL] [Abstract][Full Text] [Related]
10. Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.
Tsang RSW; Ahmad T; Tyler S; Lefebvre B; Deeks SL; Gilca R; Hoang L; Tyrrell G; Van Caeseele P; Van Domselaar G; Jamieson FB
Int J Infect Dis; 2018 Apr; 69():55-62. PubMed ID: 29414677
[TBL] [Abstract][Full Text] [Related]
11. [Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from 2007-2013].
Křížová P; Musílek M; Vacková Z; Bečvářová Z; Kozáková J
Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):61-8. PubMed ID: 24730996
[TBL] [Abstract][Full Text] [Related]
12. Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020).
Honskus M; Krizova P; Okonji Z; Musilek M; Kozakova J
PLoS One; 2023; 18(3):e0282971. PubMed ID: 36913385
[TBL] [Abstract][Full Text] [Related]
13. Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001-2010.
Jamieson FB; Rawte P; Deeks SL; Zhou J; Law DKS; Deng S; Tsang RSW
J Med Microbiol; 2013 Jan; 62(Pt 1):46-55. PubMed ID: 23038803
[TBL] [Abstract][Full Text] [Related]
14. Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
Bettencourt C; Nogueira P; Paulo Gomes J; João Simões M
Vaccine; 2022 Aug; 40(33):4772-4779. PubMed ID: 35778280
[TBL] [Abstract][Full Text] [Related]
15. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
[TBL] [Abstract][Full Text] [Related]
16. Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland.
Bodini M; Brozzi A; Giuliani M; Nohynek H; Vainio A; Kuusi M; De Paola R; Pizza M; Medini D; Toropainen M; Serino L; Muzzi A
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938694
[TBL] [Abstract][Full Text] [Related]
17. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
[TBL] [Abstract][Full Text] [Related]
18. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of invasive
Sereikaitė E; Plepytė R; Petrutienė A; Stravinskienė D; Kučinskaitė-Kodzė I; Gėgžna V; Ivaškevičienė I; Žvirblienė A; Plečkaitytė M
Front Cell Infect Microbiol; 2023; 13():1136211. PubMed ID: 36875527
[No Abstract] [Full Text] [Related]
20. Neisseria meningitidis serogroup B carriage by adolescents and young adults living in Milan, Italy: Prevalence of strains potentially covered by the presently available meningococcal B vaccines.
Terranova L; Principi N; Bianchini S; Di Pietro G; Umbrello G; Madini B; Esposito S
Hum Vaccin Immunother; 2018 May; 14(5):1070-1074. PubMed ID: 29584565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
